Sandra Falagan
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits.
Journal: Frontiers in immunology
Published: October 30, 2024
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 08, 2023
Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer.
Journal: World journal of clinical oncology
Published: April 28, 2021
A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 21, 2020
Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer.
Journal: Cancer biology & medicine
Published: October 17, 2019
Antinuclear antibodies and cancer: A literature review.
Journal: Critical reviews in oncology/hematology
Published: December 17, 2017
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.
Journal: BMC cancer
Published: August 20, 2016
Genotyping the Host in the Battle Against Cancer.
Journal: European urology focus
Published: April 21, 2016
Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 29, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026